Accelerate Diagnostics Inc

LTS:0H8E (USA)   Ordinary Shares
$ 1.48 (0%) Dec 23
At Loss
Market Cap:
$ 27.55M
Enterprise V:
$ 65.61M
Volume:
-
Avg Vol (2M):
289.00
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
289.00

Business Description

Accelerate Diagnostics Inc
NAICS : 325413 SIC : 5047
ISIN : US00430H2013

Share Class Description:

LTS:0H8E: Ordinary Shares
Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Name Current Vs Industry Vs History
Cash-To-Debt 0.36
Equity-to-Asset -1.5
Debt-to-Equity -1.22
Debt-to-EBITDA -1.52
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -34.12
Distress
Grey
Safe
Beneish M-Score -6.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.06
9-Day RSI 32.53
14-Day RSI 34.36
6-1 Month Momentum % 27.65
12-1 Month Momentum % -58.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.5
Quick Ratio 1.34
Cash Ratio 1.15
Days Inventory 132.01
Days Sales Outstanding 72.46
Days Payable 187.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.2
Shareholder Yield % -65.56

Financials (Next Earnings Date:2025-03-28 Est.)

LTS:0H8E's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Accelerate Diagnostics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 11.909
EPS (TTM) ($) -2.64
Beta -1.52
Volatility % 93.72
14-Day RSI 34.36
14-Day ATR ($) 0.031904
20-Day SMA ($) 1.589215
12-1 Month Momentum % -58.62
52-Week Range ($) 0.8518 - 4.2826
Shares Outstanding (Mil) 25.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Accelerate Diagnostics Inc Filings

Filing Date Document Date Form
No Filing Data

Accelerate Diagnostics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Accelerate Diagnostics Inc Frequently Asked Questions

What is Accelerate Diagnostics Inc(LTS:0H8E)'s stock price today?
The current price of LTS:0H8E is $1.48. The 52 week high of LTS:0H8E is $4.28 and 52 week low is $0.85.
When is next earnings date of Accelerate Diagnostics Inc(LTS:0H8E)?
The next earnings date of Accelerate Diagnostics Inc(LTS:0H8E) is 2025-03-28 Est..
Does Accelerate Diagnostics Inc(LTS:0H8E) pay dividends? If so, how much?
Accelerate Diagnostics Inc(LTS:0H8E) does not pay dividend.

Press Release

Subject Date
No Press Release